Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alitretinoin versus cyclosporine for moderate to very severe hand eczema
2015-003488-12Phase 3Active
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2016
- Modality
- Small Molecules, Peptides, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hand dermatitis comparing Oral alitretinoin with Oral cyclosporine (2 arms). Primary endpoint: Severity of hand eczema. Started Jun 2016; status: active.
02
Drugs
alitretinoincyclosporine
03
Conditions
hand dermatitis
Beyond the preview
Go deeper on 2015-003488-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003488-12.